Liz Highleyman

Nearly 600 people have died this year, far above the fatality rate of last year’s global outbreak.

While not cured, the man has maintained viral suppression for more than two decades after stopping antiretroviral therapy.

Every-other-month cabotegravir injections offer greater protection against HIV and do not appear to interact with gender-affirming hormones.

In limited studies to date, semaglutide and other weight-loss drugs appear to be safe and effective for people living with HIV.

MASLD and MASH can lead to liver fibrosis, cirrhosis and liver cancer.

Two daily pill options and long-acting injections effectively prevent HIV.

PrEP rollout in Africa has been slow, and offering more prevention options could increase uptake and encourage consistent use.

Some experts suggest changing treatment guidelines to include Cabenuva for those without viral suppression when other options aren’t working

Some HIV meds have been linked to fatty liver disease and weight gain.

So far, traditional HIV vaccines that stimulate the production of antibodies have failed in large trials.

Health officials and advocates hope the recommendation will help increase PrEP uptake.

Over a quarter of participants said they had an unmet need for mental health services.

Men with repeat or post-vaccination infections had fewer and less severe mpox sores that healed more quickly.

However, only 24% of people with hepatocellular carcinoma received direct-acting antiviral therapy.

An increase in fatty liver disease could double liver cancer cases and nearly triple the need for transplants by 2050.